Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Applied Health Economics and Health Policy|June 7, 2019
Cost Effectiveness of the Third-Generation Tyrosine Kinase Inhibitor (TKI) Ponatinib, vs. Second-Generation TKIs or Stem Cell Transplant, as Third-Line Treatment for Chronic-Phase Chronic Myeloid LeukemiaCarsten Hirt, Sergio Iannazzo, Silvia Chiroli, et al.British Journal of Haematology|October 8, 2025
Empirical and projected economic burden of chronic myeloid leukaemia in Sweden from 2015 to 2030: A population-based studyEnoch Yi-Tung Chen, Paul W Dickman, Fabrizio Di Mari, et al.Annals of Internal Medicine|June 14, 2016
Cardiovascular Events Associated With Use of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A Population-Based Cohort StudyTorsten Dahlén, Gustaf Edgren, Mats Lambe, et al.JAMA|September 12, 2023
Intracerebral Hemorrhage Among Blood Donors and Their Transfusion RecipientsJingcheng Zhao, Klaus Rostgaard, Elsa Lauwers, et al.European Journal of Haematology|July 19, 2016
Advanced phase chronic myeloid leukaemia (CML) in the tyrosine kinase inhibitor era - a report from the Swedish CML registerStina Söderlund, Torsten Dahlén, Fredrik Sandin, et al.American Journal of Hematology|January 11, 2022
Adverse outcomes in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: Follow-up of patients diagnosed 2002-2017 in a complete coverage and nationwide agnostic register studyTorsten Dahlén, Gustaf Edgren, Per Ljungman, et al.British Journal of Haematology|March 30, 2021
Successful tyrosine kinase inhibitor discontinuation outside clinical trials - data from the population-based Swedish chronic myeloid leukaemia registryHjalmar Flygt, Fredrik Sandin, Torsten Dahlén, et al.Nature Communications|December 5, 2019
Estimating heritability and genetic correlations from large health datasets in the absence of genetic dataGengjie Jia, Yu Li, Hanxin Zhang, et al.Pageof 2